HDAC/σ1R Dual-Ligand as a Targeted Melanoma Therapeutic

Leotta, C. G., Barbaraci, C., Fiorito, J., Coco, A., di Giacomo, V., Amata, E., Marrazzo, A., & Pitari, G. M. (2025). HDAC/σ1R Dual-Ligand as a Targeted Melanoma Therapeutic. Pharmaceuticals, 18(2), 179. https://doi.org/10.3390/ph18020179

Authors:

Claudia Giovanna Leotta

Carla Barbaraci

Jole Fiorito

Alessandro Coco

Viviana di Giacomo

Emanuele Amata

Agostino Marrazzo

Giovanni Mario Pitari

Affiliated Authors:

Jole Fiorito

Columbia Affiliation:

Vagelos College of Physicians and Surgeons
- Department of Medicine
  Division of Nephrology

Author Keywords:

hdaci

angiogenesis

cancer proliferation

cell spreading

dual-ligands

melanoma

σ1 receptor

elink

Publication Type:

Article

Unique ID:

10.3390/ph18020179

PMID:

40005993

DOI:

10.3390/ph18020179

Journal:

Pharmaceuticals

Publication Date:

2025-02-26

Data Source:

PubMed

Source Link:

View PubMed Record

Record Created:

Monday, March 3, 2025 - 14:55